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Experimental Section 
 
General Considerations 
 All air- and/or water-sensitive compounds were manipulated using standard vacuum 
or Schlenk line techniques or in an inert atmosphere glove box. The solvents for air- and 
moisture-sensitive reactions were dried over sodium benzophenone ketyl, calcium hydride, 
or by the method of Grubbs.1 All NMR solvents were purchased from Cambridge Isotopes 
Laboratories, Inc. and dried over sodium benzophenone ketyl or calcium hydride. Unless 
mentioned otherwise, reagents were used as received from commercial suppliers without 
further purification. Nickel(II)acetate, palladium(II)acetate, chlorodiisopropylphosphine, 
boron tribromide, silver trifluoromethanesulfonate, 1.7 M tBuLi in pentane, 
diisopropylethylamine, 1,4-dimethoxybenzene, were purchased from Sigma Aldrich. (1,5-
cyclooctadiene)palladium(II)chloride, bis(1,5-cyclooctadiene)-Ni(0), tetrakis-
(triphenylphosphine)palladium(0), tris-(dibenzylideneacetone)-dipalladium(0), were 
purchased from Strem Chemicals Inc.Iodine monochloride was purchased from Alfa Aesar. , 
2-Bromophenylboronic acid was purchased from Ark Pharm. 2.1 M methyl chloromethyl 
ether (MOMCl) in toluene,2 (2,2’-bipyridine)(1,5-cyclooctadiene)nickel(0),3 1,4-dimethoxy-
2,5-diiodobenzene,4 2,5-diiodo-1,4-hydroquinone,5 and 1-Me6 were made according to 
literature procedures. All 1H, 13C, and 31P spectra were recorded on Varian Mercury 300 
MHz, or Varian INOVA-500 or 600 MHz spectrometers at room temperature. Chemical 
shifts for 1H and 13C NMR data are reported relative to residual solvent peaks.7 31P NMR 
chemical shifts are reported with respect to the deuterated solvent used to lock the 
instrument. Solution IR spectra were obtained as solution samples using a CaF2 window cell 
on a Thermo Scientific Nicolet 6700 FT-IR spectrometer. In situ solution IR spectra were 
recorded on an iC10 ReactIR (Mettler Toledo) equipped with a K4 conduit and a SiComp 
Sentinel sensor in a custom-made glass vessel. The UV/Vis spectra were recorded on a 
Varian Cary Bio 50 spectrophotometer. Low-temperatured UV/Vis spectra were obtained 
using a Varian dip-probe (661.202-UV, 10 mm) and custom-made glass vessel. Elemental 
analyses were performed by Robertson Microlit Laboratories, Ledgewood, NJ. 
 
Synthetic Scheme for 2,5-bis(2-diisopropylphosphinophenyl)-1,4-hydroquinone (1-H) 
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Synthesis of 2,5-diiodo-1,4-bis(methoxymethylether)hydroquinone (A) 
 The synthesis of 2,5-diiodo-1,4-bis(methoxymethylether)hydroquinone has been 
previously reported, however this protocol provides an alternative synthetic route. 2,5-
diiodo-1,4-hydroquinone (2 g, 5.53 mmol, 1 equiv) was added to a 3-neck flask under a 
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counterflow of nitrogen. Degassed, anhydrous dichloromethane (100 mL) was then added 
with a cannula to yield a suspension. Diisopropylethylamine (11.6 mL, 66.3 mmol, 12 equiv) 
was then added with a syringe and the reaction mixture allowed to stir for 1 minute. 
Methylchloromethylether was then added (~2.1 M in PhMe, 26.3 mL, 55.3 mmol, 10 equiv) 
with a syringe and the reaction was allowed to stir for 3-4 hours during which time the 
solution became homogenous. The reaction was monitored by GC-MS until all starting 
material was consumed. The reaction mixture was then washed with a saturated sodium 
bicarbonate solution. The organic layer was then collected and dried with magnesium sulfate 
before volatiles were removed by rotary evaporation to yield the clean product as an off-
white residue. Characterization matched previous literature reports. Yield: 2.07 g (83 %). 
 
Synthesis of 2,5-bis(2-bromophenyl)-1,4-(methoxymethylether)hydroquinone (B) 
The Suzuki coupling to produce the terphenyl product was run as a modification of 
literature procedure.8 A Schlenk tube fitted with a Teflon stopper was charged with 2,5-
diiodo-1,4-bis(methoxymethylether)hydroquinone (500 mg, 1.11 mmol, 1 equiv.), 2-bromo-
phenylboronic acid (468.6 mg, 2.33 mmol, 2.1 equiv.), and K2CO3 (921.3 mg, 6.67 mmol, 6 
equiv.). Toluene (26 mL), ethanol (6 mL), and water (6 mL) were then transferred to the 
Schlenk tube along with a magnetic stirbar. The mixture was degassed by two freeze pump 
thaw cycles and then put under positive nitrogen pressure. Under a strong counterflow of 
nitrogen, Pd(PPh3)4 (64.2 mg, 0.056 mmol, 0.05 equiv.) was added and the solution became a 
pale yellow color. The reaction mixture was then heated to 65 ºC and stirred for 16-24 hrs 
while monitoring the reaction by GC-MS. The volatiles were then removed on a rotovap and 
the residue extracted using dichloromethane and water. The organic layer was then collected 
and dried using magnesium sulfate before volatiles were removed on a rotovap. Following 
recrystallation from dichloromethane-methanol the product was obtained as off-white 
crystalline powder. Yield: 400 mg (71 %). 1H NMR (500 MHz, CDCl3) δ 7.67 (d, JHH = 8.0 
Hz, ArH, 2H), 7.37 (m, ArH, 4H), 7.25 – 7.20 (m, ArH, 2H), 7.06 (s, central-ArH, 2H), 5.02 
(broad s, OCH2O, 4H), 3.33 (s, OCH3, 6H). 13C NMR (126 MHz, CDCl3) δ 149.23 (s), 
139.54 (s), 132.68 (s), 132.17 (broad s), 131.93 (s), 129.00 (s), 127.11 (s), 124.21 (s), 118.74 
(s), 96.14 (s), 56.20 (s). GC-MS (m/z): Calcd, 508.0 (M+). Found: 508.0 (M+), FAB-MS 
(m/z): Calcd, 506.9630 (M+). Found: 506.9623 (M+). 
 
Synthesis of 2,5-bis(2-(diisopropylphosphino)phenyl)-1,4-hydroquinone (1-H) 
Phosphination run as a modification of literature procedures. A Schlenk tube fitted 
with a screw-in Telfon stopper was charged with 2,5-bis(2-bromophenyl)-1,4-
bis(methoxymethylether)hydroquinone (1 g, 1.96 mmol, 1 equiv.) and a magnetic stirbar. 
Tetrahydrofuran (60 mL) was then to the Schlenk tube. The reaction was cooled to -78 ºC 
and tert-butyllithium (1.7 M pentane solution, 5.4 mL, 8.07 mmol, 4.1 equiv.) was added 
while stirring to generate a pale yellow solution. The reaction mixture was allowed to warm 
to room temperature and then stirred for an additional hour. During this time the solution 
became a cloudy suspension. Chlorodiisopropyl phosphine (0.656 mL, 4.13 mmol, 2.1 
equiv.) was then added to the reaction via syringe. The solution immediately became a 
homogenous pale yellow solution which was allowed to stir for 16 hours. The volatiles were 
then removed under reduced pressure on the Schlenk line. Acidified methanol (13 mL 
concentrated HCl, 60 mL MeOH) was quickly degassed on the Schlenk line and then 
cannula transferred to the dried reaction residue which formed a pale yellow homogeneous 
solution. The reaction mixture was allowed to stir for 4 hrs at 70 °C to ensure complete 
removal of the methoxymethylether protecting group before all volatiles were removed 
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under reduced pressure. The reaction was then brought into a wet inert atmosphere 
glovebox and extracted with dichloromethane. The organic layer was washed with saturated 
aqueous potassium carbonate followed by saturated ammonium chloride. The organic layer 
was then dried over magnesium sulfate and the volatiles were then removed under reduced 
pressure. After drying the residue overnight with heating to 60 °C the reaction was then 
brought into the dry inert atmosphere glovebox. The residue was washed with cold pentanes 
and then cold ether to yield the pure product as an off-white solid. Yield: 460 mg (47 %). 1H 
NMR spectra of product is broad at room temperature due to hindered rotation around 
aryl–aryl bonds. This is corroborated by 31P NMR where two distinct peaks are observed at 
room temperature. 1H NMR (300 MHz, C6D6) δ 7.22 (broad s, ArH, 4H), 7.05 (broad s, 
ArH, 4H), 5.78 (broad s, OH, 1H), 5.42 (broad s, OH, 1H), 1.93 (broad s, CH, 2H), 1.71 
(broad s, CH, 2H), 0.84 (unresolved m, CH3, 24H). 13C{1H} NMR (126 MHz, C6D6) δ 
145.76 (s), 134.38 (d, JPC = 45.8 Hz), 131.94 (s), 129.24 (s), 127.01 (s), 121.76 (s), 120.72 (s), 
25.35 (s), 21.97 (s), 21.33 (s), 19.89 (s), 19.27 (s), 18.18 (s). At room temperature, 1 shows 
two distinct 31P NMR signals due to hindered rotation around the aryl-aryl bonds. 31P{1H} 
NMR (121 MHz, C6D6) δ 1.80 (s), -0.06 (s). FAB-MS (m/z): Calcd: 495.2578 (M+). Found: 
495.2582 (M+). 
 
Synthesis of Compound 2 
Compound 1-H (100 mg, 0.202 mmol, 1 equiv.) was dissolved in tetrahydrofuran (6 
mL) and transferred to a Schlenk tube fitted with a screw-in Teflon stopper. Ni(OAc)2 (35.7 
mg, 0.202 mmol, 1 equiv.) was suspended in tetrahydrofuran and then added to the solution 
of 1. The Schlenk tube was then sealed and heated to 80 °C for 16 hours outside the 
glovebox during which time to solution became a cloudy green. The reaction mixture was 
then dried under reduced pressure and brought back into the inert atmosphere glovebox. 
The crude residue was suspended in diethyl ether and filtered onto a Celite pad. The green 
solid was washed with additional diethyl ether until the washes became colorless. The 
product was brought through the Celite pad using tetrahydrofuran. The combined 
tetrahydrofuran filtrate was dried under reduced pressure to yield the clean product as a 
green powder. Yield: 65 mg (58 %). 1H NMR (500 MHz, CD2Cl2) δ 7.62 (d, JHH = 7.6 Hz, 
ArH, 2H), 7.58 (t, JHH = 7.4 Hz, ArH, 2H), 7.50 (t, JHH = 6.7 Hz, ArH, 2H), 7.45 (t, JHH = 7.5 
Hz, ArH, 2H), 6.16 (s, central ArH, 2H), 2.56 (m, CH, 2H), 2.28 (m, CH, 2H), 1.32 – 1.24 
(m, CH3, 12H), 1.21 (dd, JPH = 16.1 Hz, JHH = 7.0 Hz, CH3, 6H), 1.09 (dd, JPH = 15.8 Hz, JHH 
= 7.0 Hz, CH3, 6H). 13C{1H} NMR (126 MHz, CD2Cl2) δ 162.79 (s), 146.43 – 145.62 (m), 
138.53 – 136.77 (m), 130.95 (d, JPC = 16.1 Hz), 127.68 (s), 120.33 – 117.76 (m), 96.46 (s), 
27.29 (m), 19.99 (s), 17.97 (s), 17.82 (s), 17.43 (s). 31P{1H} NMR (121 MHz, CD2Cl2) δ 54.30 
(s). IR (CaF2 window, THF, cm-1) C-O: 1597. Anal. Calcd. for: C30H38NiO2 (2) (%): C, 65.36; 
H, 6.95. C31H40Cl2NiO2 (2•DCM) (%): C, 58.53; H, 6.34. Found: C, 58.94; H, 6.18. 
 
Synthesis of Complex 3 using Pd(OAc)2 
Compound 1-H (100mg, 0.202 mmol, 1 equiv.) was dissolved in tetrahydrofuran (10 
mL) and transferred to a 20 mL scintillation vial. Palladium diacetate (45.4 mg, 0.202 mmol, 
1 equiv.) was added as a tetrahydrofuran solution, which in the immediate formation of a 
deep purple solution. The reaction mixture was allowed to stir for 16 hours before volatiles 
were removed under reduced pressure to yield a purple residue. The residue was filtered 
through a Celite pad with tetrahydrofuran. The combined tetrahydrofuran filtrate was dried 
under reduced pressure to yield the product as a purple powder. Yield: 70 mg (58 %). 
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Synthesis of Compound 3 using Pd2(dba)3 and O2 
Compound 1-H (300 mg, 0.606 mmol, 1 equiv.) was dissolved in tetrahydrofuran (10 
mL) and then transferred to a 20 mL scintillation vial. Tris(dibenzylideneacetone 
dipalladium(0) (277.7 mg, 0.303 mmol, 0.5 equiv.) was then partially dissolved in 
tetrahydrofuran (10 mL) and added to the solution of 1. The reaction mixture was allowed to 
stir for 30 minutes. The scintillation vial was then removed from the inert atmosphere 
glovebox and exposed to air and allowed to stir for 1 hour. The reaction immediately turned 
a deep purple upon exposure to air. The reaction mixture was then poured onto a silica plug 
that had been wet packed with ethyl acetate (Note: the product is not indefinitely stable on 
silica and should be eluted quickly from the plug column). Excess dibenzylideneacetone was 
eluted with ethyl acetate as evidenced by a yellow band. The product was then eluted with 
methanol taking care to collect only the purple band. The methanol filtrate was then dried 
under reduced pressure. The purple residue was dried on the Schlenk line overnight and 
brought into the glovebox where it was dissolved in dry dichloromethane and redried under 
reduced pressure to yield the product as a purple powder. Yield: 219.7 mg (60 %). 1H NMR 
(300 MHz, CD2Cl2) δ 7.62 – 7.54 (m, ArH, 2H), 7.53 – 7.48 (m, ArH, 4H), 7.47 – 7.37 (m, 
ArH, 2H), 6.10 (s, central ArH, 2H), 2.46 (dtt, CH, 2H), 2.33 (m, CH, 2H), 1.13 (m, CH3, 
24H). 13C{1H} NMR (126 MHz, CD2Cl2) δ 165.45 (s), 146.28 – 145.30 (m), 140.90 – 139.75 
(m), 132.41 (s), 130.78 (s), 129.82 (s), 128.81 (vt, JPC = 7.9 Hz), 127.82 (d, JPC = 2.5 Hz), 
102.64 (s), 28.18 – 27.56 (m), 26.85 – 25.79 (m), 19.38 (t, JPC = 3.7 Hz), 18.70 (vt, JPC = 3.6 
Hz), 18.34 (s), 18.05 (s). 31P{1H} NMR (121 MHz, CD2Cl2) δ 55.02 (s). IR (CaF2 window, 
THF, cm-1) C-O: 1603. Anal. Calcd. for: C30H38FO4P2Pd (3) (%): C, 60.16; H, 6.39. Anal. 
Calcd. for: C31H40Cl2O4P2Pd (3•DCM) (%): C, 54.44; H, 5.90. Found: C, 54.90; H, 6.00. 
 
Synthesis of Compound 4-H 
Compound 1-H (300 mg, 0.606 mmol, 1 equiv.) was dissolved in tetrahydrofuran (10 
mL) and transferred to a Schlenk tube fitted with a screw-in Teflon stopper. (1,5-
cyclooctadiene)palladium(II) dichloride (173.2 mg, 0.606 mmol, 1 equiv.) was then added as 
a partially dissolved suspension in tetrahydrofuran (15 mL). The reaction mixture was 
allowed to stir for 2 hours during which time the reaction became a homogeneous orange 
solution. (1,5-cyclooctadiene)(2,2’-bipyridine)nickel(0) (195.6 mg, 0.606 mmol, 1 equiv.) was 
then dissolved in tetrahydrofuran (15 mL) and transferred to the reaction mixture. This 
resulted in an immediate color change to a heterogeneous brown/orange suspension. After 
stirring for 15 minutes the reaction mixture was filtered through a Celite pad with washing 
with additional tetrahydrofuran until washes became less colored. The combined 
tetrahydrofuran filtrate was dried under reduced pressure to yield a brown residue. This 
residue was then redissolved in benzene and lyophilized to yield the product as a brown 
powder. Yield: 305 mg (84 %). Note: the product is not indefinitely stable in solution and 
eventually decomposes to a mixture of species. However, it is stable in the solid state. 1H 
NMR (300 MHz, C6D6) δ 7.41 – 7.29 (m, ArH, 4H), 7.12 – 7.03 (m, ArH, 4H), 6.94 (s, 
central ArH, 2H), 4.14 (s, OH, 2H), 1.88 (m, CH, 4H), 1.35 (m, CH3, 12H), 0.95 (m, CH3, 
12H). 13C{1H} NMR (126 MHz, C6D6) δ 145.26 (s), 144.83 (vt, JPC = 10.2 Hz), 135.02 (vt, JPC 
= 9.7 Hz), 132.01 (s), 129.67 (s), 128.57 (s), 128.19 (s), 124.22 (s), 29.15 (vt, JPC = 6.1 Hz), 
27.82 (vt, JPC = 6.2 Hz), 22.04 (vt, JPC = 8.3 Hz), 21.82 (vt, JPC = 9.1 Hz), 20.80 – 20.30 (m). 
31P{1H} NMR (121 MHz, C6D6) δ 33.85 (s). Anal. Calcd. for: C30H40O2P2Pd (4) (%): C, 
59.95; H, 6.71. Found: C, 60.21; H, 6.71. 
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Synthesis of Compound 5-H 
Compound 1-H (100.7 mg, 0.204 mmol, 1 equiv.) was dissolved in tetrahydrofuran 
(8 mL) and added to a 20 mL scintillation vial containing (1,5-cyclooctadiene)palladium(II) 
dichloride (58.1 mg, 0.204 mmol, 1 equiv.). The reaction mixture was allowed to stir for 2 
hours during which time the solution became a homogeneous orange. Silver triflate (52.3 
mg, 0.204 mmol, 1 equiv.) was then added as a tetrahydrofuran solution resulting in an 
immediate color change to a dark red. The solution was allowed to stir for 30 minutes before 
filtering the solution through a Celite pad. Tetrahydrofuran washes eluted further product 
from the Celite pad. The combined tetrahydrofuran filtrate was dried under reduced pressure 
to yield a red residue. This residue was recrystallized from acetonitrile:diethyl ether to yield 
the product as dark red crystals. Yield: 56.1 mg (31.6 %). Note: the product is not indefinitely 
stable in solution and eventually decomposes to a mixture of species. However, it is stable in 
the solid state. 1H NMR (300 MHz, CD3CN) δ 8.18 (broad s, OH, 2H), 7.86 (m, ArH, 2H), 
7.79 – 7.65 (m, ArH, 4H), 7.59 (m', ArH, 2H), 6.72 (s, central ArH, 2H), 3.12 (m, CH, 4H), 
1.42 – 1.07 (m, CH3, 24H). 13C{1H} NMR (126 MHz, CD3CN) δ 148.17 (s), 143.58 (s), 
133.80 (s), 133.23 (s), 132.55 (s), 130.76 (s), 130.14 (s), 128.81 (s), 128.28 (s), 27.35 (s), 26.89 
(vt, JPC = 11.5 Hz), 19.61 (s), 19.34 (s), 18.74 (s). 31P{1H} NMR (121 MHz, CD3CN) δ 34.22 
(s). 19F NMR (282 MHz, CD3CN) δ -79.40 (s). Anal. Calcd. for: C31H44F3O5P2PdS (5) (%): C, 
47.40; H, 4.51. Found: C, 47.62; H, 5.13. 
 
Synthesis of Compound 6-H 
Pyridinium triflate (44.7 mg, 0.195 mmol, 1 equiv.) was partially dissolved in 
tetrahydrofuran (4 mL) in a 20 mL scintillation vial. Compound 4-H (117.2 mg, 0.195 mmol, 
1 equiv.) was the added as a tetrahydrofuran solution which resulted in an immediate 
lightening of the solution from yellow/brown to yellow. After stirring for 16 hours the 
reaction mixture was dried under reduced pressure to yield the product as a foamy 
yellow/orange solid in quantitative yield. 1H NMR (300 MHz, CD3CN) δ 7.84 – 7.75 (m, 
ArH, 2H), 7.71 – 7.53 (m, ArH, 6H), 7.42 (broad s, OH, 2H), 6.79 (s, central ArH, 4H), 2.46 
(m, CH, 4H), 1.19 – 1.01 (m, CH3, 18H), 0.94 (m, CH3, 6H), -16.33 (t, JPH = 8.5 Hz, PdH, 
1H). 13C{1H} NMR (126 MHz, CD3CN) δ 144.58 (s), 143.99 (vt, JPC = 7.2 Hz), 132.28 (s), 
131.11 (s), 130.12 (s), 128.38 (s), 126.64 (s), 125.97 (vt, JPC = 19.2 Hz), 110.30 (s), 28.11 (vt, 
JPC = 13.1 Hz), 27.30 (vt, JPC = 12.5 Hz), 19.68 (s), 19.44 (s), 18.60 (s), 18.41 (s). 31P{1H} 
NMR (121 MHz, CD3CN) δ 41.57 (d, JPH = 6.7 Hz). 19F NMR (282 MHz, CD3CN) δ -79.34 
(s). Anal. Calcd. for: C31H41F3O5P2PdS (6) (%): C, 49.57; H, 5.50. Found: C, 49.32; H, 5.36. 
 
Synthesis of Compound 7-H 
Compound 1-H (129.5 mg, 0.262 mmol, 1 equiv.) was dissolved in tetrahydrofuran 
(8 mL) and then added to a 20 mL scintillation vial with silver triflate (67.2 mg, 0.262 mmol, 
1 equiv.). The reaction mixture was allowed to stir for 3 hours to yield a pale pink solution 
before being dried under reduced pressure. The residue was then dissolved in minimal 
acetonitrile and filtered through a Celite pad, which removed the pinkish color. The product 
was then recrystallized from an acetonitrile:diethyl ether vapor diffusion to yield white 
crystalline needles. Yield: 134 mg (68 %). 1H NMR (500 MHz, CD3CN) δ 7.81 – 7.77 (m, 
ArH, 2H), 7.72 – 7.68 (t, JHH = 7.6 Hz, 2H), 7.63 (t, JHH = 7.7 Hz, ArH, 2H), 7.58 (dq, JHH = 
7.5 Hz, JHH = 1.8 Hz, ArH, 2H), 6.98 (broad s, OH, 2H), 6.85 (s, central ArH, 2H), 2.52 (m, 
CH, 4H), 1.32 – 1.15 (m, CH3, 12H), 1.02 (m, CH3, 12H). 13C{1H} NMR (126 MHz, 
CD3CN) δ 147.80 (s), 144.47 (vt, JPC = 8.7 Hz), 132.62 (d), 131.00 (s), 130.30 (s), 128.58 (s), 
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126.91 (d, JPC = 5.3 Hz), 126.88 – 126.48 (m), 118.16 (s), 26.12 (dd), 25.78 – 25.34 (m), 20.93 
(vt, JPC = 5.9 Hz), 20.65 (vt, JPC = 5.9 Hz), 19.50 (m). 31P{1H} NMR (121 MHz, CD3CN) δ 
28.33 (d, JPAg = 559.7 Hz), 28.33 (d, JPAg = 484.9 Hz). 19F NMR (282 MHz, CD3CN) δ -79.32 
(s). Anal. Calcd. for: C31H40AgF3O5P2S (7) (%): C, 49.54; H, 5.37. Found: C, 49.77; H, 5.15. 
 
Synthesis of Compound 4-Me 
Compound 1-Me (327.3 mg, 0.626 mmol, 1 equiv.) was dissolved in tetrahydrofuran 
(10 mL) and transferred to a Schlenk tube fitted with a screw-in Teflon stopper. (1,5-
cyclooctadiene)palladium(II) dichloride was then added as a partially dissolved suspension in 
tetrahydrofuran (15 mL). The reaction mixture was allowed to stir for 2 hours during which 
time the solution became a homogeneous yellow/orange. (1,5-cyclooctadiene)(2,2’-
bipyridine)nickel(0) was added as a solution in tetrahydrofuran (20 mL) which resulted in 
immediate consumption of the purple nickel complex and the formation of a heterogeneous 
orange solution. The reaction mixture was stirred for an additional 30 minutes before 
filtering through a Celite pad. Additional tetrahydrofuran was used to wash product through 
the Celite pad. The combined tetrahydrofuran filtrate was dried under reduced pressure to 
yield an orange residue. This residue was redissolved in benzene and lyophilized to yield the 
product as an orange powder. Yield: 385.8 mg (98 %). 1H NMR (300 MHz, C6D6) δ 7.63 (m, 
ArH, 2H), 7.45 (m, ArH, 12H), 7.22 (m, ArH, 4H), 6.86 (s, central ArH, 2H), 3.49 (s, OCH3, 
6H), 1.96 ( m, CH, 4H), 1.36 (m, CH3, 12H), 1.00 (m, CH3, 12H). 13C{1H} NMR (126 MHz, 
C6D6) δ 149.30 (s), 147.29 (vt, JPC = 10.0 Hz), 133.88 (vt, JPC = 10.9 Hz), 131.25 (s), 129.95 
(s), 126.81 (s), 125.74 (s), 55.09 (s), 28.58 (vt, JPC = 6.2 Hz), 28.40 (t, JPC = 6.3 Hz), 22.18 (vt, 
JPC = 8.6 Hz), 21.97 (vt, JPC = 8.8 Hz), 20.82 (s), 20.52 (s). 31P{1H} NMR (121 MHz, C6D6) δ 
33.81 (s). Anal. Calcd. for: C32H44O2P2Pd (9) (%): C, 61.10; H, 7.05. Found: C, 60.62; H, 6.81. 
 
Synthesis of Compound 6-Me 
Pyridinium triflate (94.8 mg, 0.413 mmol, 1 equiv.) was partially dissolved in 
tetrahydrofuran (5 mL) in a 20 mL scintillation vial. Compound 4-Me (260.3 mg, 0.413 
mmol, 1 equiv.) was then added as a tetrahydrofuran solution (10 mL) which resulted in an 
immediate color change from orange to yellow. After stirring for 16 hours the reaction 
mixture was dried under reduced pressure to yield the product as a foamy yellow/orange 
solid in quantitative yield. 1H NMR (300 MHz, CD3CN) δ 7.86 – 7.75 (m, ArH, 2H), 7.75 – 
7.51 (m, ArH, 6H), 6.99 (s, central ArH, 2H), 3.73 (s, OCH3, 1H), 2.55 – 2.42 (m, CH, 4H), 
1.17 – 1.01 (m, CH3, 12H), 1.00 – 0.84 (m, CH3, 12H), -16.33 (t, JPH = 9.0 Hz, PdH, 
1H).13C{1H} NMR (126 MHz, CD3CN) δ 148.03 (s), 144.17 (vt, JPC = 7.0 Hz), 132.17 (s), 
130.98 (s), 128.39 (s), 127.92 (s), 125.55 (vt, JPC = 19.0 Hz), 107.70 (s), 56.49 (d), 27.76 (vt, 
JPC = 13.3 Hz), 27.18 (vt, JPC = 13.2 Hz), 19.63 (s), 19.24 (s), 18.55 (s), 18.22 (s). 31P{1H} 
NMR (121 MHz, CD3CN) δ 41.93 (s). 19F NMR (282 MHz, CD3CN) δ -79.37 (s). Anal. 
Calcd. for: C33H45F3O5P2PdS (10) (%): C, 50.87; H, 5.82. Found: C, 50.19; H, 5.47. 
 
In Situ Preparation of Compound 8-Me 
4-Me (11.6 mg, 0.0184 mmol, 1 equiv) was dissolved d8-THF and transferred to a J-
Young tube. The solution was then frozen and the headspace removed under vacuum. 
Excess O2 (1 atm) was then added and the solution was carefully mixed to avoid warming 
the solution. Immediate and quantitative conversion to 8-Me was observed by NMR at -78 
°C. Note: The compound is stable at low temperatures with no decomposition detected by 
NMR for hours at -40 °C or two weeks at -78 °C. However, around 0 °C decomposition to a 
mixture of species in observed. Solutions can be degassed to remove excess O2 by placing 
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solutions under dynamic vacuum at -78 °C if prepared in a Schlenk tube or by multiple 
freeze-pump-thaw cycles if care is taken not to warm the solution above -40 °C. All NMR 
characterization was obtained at -40 °C. 1H NMR (500 MHz, d8-THF) δ 7.62 (dd, JHH = 7.8 
Hz, JHH = 5.1 Hz, ArH, 1H), 7.54 (dd, JHH = 7.8, JHH = 5.1 Hz, ArH, 1H), 7.52 – 7.46 (m, 
ArH, 4H), 7.44 – 7.38 (m, ArH, 2H), 6.87 (s, central aryl ArH, 1H), 6.66 (s, central aryl ArH, 
1H), 3.56 (s, OCH3, 3H), 3.47 (s, OCH3, 3H), 2.67 (m, CH, 1H), 2.59 (m, CH, 1H), 1.98 (m, 
CH, 2H), 1.37 (m, CH3, 12H), 1.13 – 1.04 (m, CH3, 6H), 0.85 (m, CH3, 6H). 13C{1H} NMR 
(126 MHz, d8-THF) δ 151.03 (s), 149.81 (s), 146.60 (d, JPC = 16.0 Hz), 145.46 (d, JPC = 16.1 
Hz), 133.84 (s), 133.06 (s), 132.99 (s), 132.77 (s), 130.28 (s), 130.09 (s), 129.66 (d, JPC = 6.1 
Hz), 129.52 (d, JPC = 5.8 Hz), 129.14 (s), 128.95 (d, JPC = 7.2 Hz), 128.78 (s), 128.61 (d, JPC = 
6.6 Hz), 128.21 (s), 127.97 (s), 127.87 (s), 127.67 (s), 127.48 (s), 126.06 (s), 125.53 (s), 113.70 
(d, JPC = 13.2 Hz), 54.43 (s), 28.36 (d, JPC = 14.2 Hz), 27.26 (d, JPC = 11.5 Hz), 25.48 (d, JPC = 
20.2 Hz), 22.70 (d, JPC = 18.0 Hz), 22.37 (d, JPC = 15.1 Hz), 20.04 (s), 19.53 (d, JPC = 13.1 
Hz), 19.33 (d, JPC = 7.1 Hz), 18.86 (d, JPC = 5.6 Hz), 17.26 (d, JPC = 4.5 Hz), 16.32 (d, JPC = 
6.0 Hz). 31P{1H} NMR (202 MHz, d8-THF) δ 34.04 (d, 2JPP = 23.8 Hz), 29.87 (d, 2JPP = 24.0 
Hz). 
 
Synthesis of Compound (3)H+ 
 6-H (13.9 mg, 0.019 mmol, 1 equiv) was dissolved in CD3CN and transferred to a J-
Young tube. The solution was then frozen and the headspace removed under vacuum. 
Excess O2 (1 atm) was then added and the sample was allowed to thaw to room temperature 
with inversion to ensure adequate mixing. A gradual color change from yellow/orange to a 
pink/red solution was observed over 6+ hours. NMR revealed quantitative conversion to a 
new species, (3)H+, that could be isolated as a red powder following removal of volatiles. 1H 
NMR (300 MHz, CD3CN) δ 7.76 – 7.51 (m, 8H), 6.39 (s, 2H), 2.63 (m, 2H), 2.54 (m, 2H), 
1.24 – 0.96 (m, 24H). 13C NMR (126 MHz, CD3CN) δ 142.35 (d, JPC = 13.7 Hz), 139.70 (d, 
JPC = 37.2 Hz), 133.34 (s), 132.23 (s), 131.57 (s), 129.09 (d, JPC = 13.6 Hz), 127.38 (s), 105.94 
(s), 28.10 (d, JPC = 19.1 Hz), 26.35 (d, JPC = 26.1 Hz), 18.73 (s), 18.07 (s), 17.83 (s), 17.23 (s). 
31P NMR (121 MHz, CD3CN) δ 64.39. 19F NMR (282 MHz, CD3CN) δ -79.34. 
 
Nuclear Magnetic Resonance Spectra 
 
 
Figure S1. 1H-NMR (500 MHz, CDCl3) spectrum of A. 
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Figure S2. 1H-NMR (500 MHz, CDCl3) spectrum of B. 
 
 
Figure S3. 13C-NMR (126 MHz, CDCl3) spectrum of B. 
 
 
Figure S4. 1H-NMR (300 MHz, C6D6) spectrum of 1-H. 
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Figure S5. 31P-NMR (121 MHz, C6D6) spectrum of 1-H. 
 
 
Figure S6. 13C-NMR (126 MHz, C6D6) spectrum of 1-H. 
 
 
Figure S7. 1H-NMR (500 MHz, CD2Cl2) spectrum of 2. 
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Figure S8. 31P-NMR (121 MHz, CD2Cl2) spectrum of 2. 
 
 
Figure S9. 13C-NMR (126 MHz, CD2Cl2) spectrum of 2. 
 
 
Figure S10. 1H-NMR (500 MHz, CD2Cl2) spectrum of 3. 
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Figure S11. 31P-NMR (121 MHz, CD2Cl2) spectrum of 3. 
 
 
Figure S12. 13C-NMR (126 MHz, CD2Cl2) spectrum of 3. 
 
 
Figure S13. 1H-NMR (500 MHz, C6D6) spectrum of 4-H. 
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Figure S14. 31P-NMR (121 MHz, C6D6) spectrum of 4-H. 
 
 
Figure S15. 13C-NMR (126 MHz, C6D6) spectrum of 4-H. 
 
 
Figure S16. 1H-NMR (500 MHz, CD3CN) spectrum of 5-H. 
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Figure S17. 31P-NMR (121 MHz, CD3CN) spectrum of 5-H. 
 
 
Figure S18. 13C-NMR (126 MHz, CD3CN) spectrum of 5-H. 
 
 
Figure S19. 19F-NMR (282 MHz, CD3CN) spectrum of 5-H. 
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Figure S20. 1H-NMR (500 MHz, CD3CN) spectrum of 6-H. 
 
 
Figure S21. 31P-NMR (121 MHz, CD3CN) spectrum of 6-H. 
 
 
Figure S22. 13C-NMR (126 MHz, CD3CN) spectrum of 6-H. 
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Figure S23. 19F-NMR (282 MHz, CD3CN) spectrum of 6-H. 
 
 
Figure S24. 1H-NMR (500 MHz, CD3CN) spectrum of 7-H. 
 
 
Figure S25. 31P-NMR (121 MHz, CD3CN) spectrum of 7-H. 
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Figure S26. 13C-NMR (126 MHz, CD3CN) spectrum of 7-H. 
 
 
Figure S27. 19F-NMR (282 MHz, CD3CN) spectrum of 7-H. 
 
 
Figure S28. 1H-NMR (500 MHz, C6D6) spectrum of 4-Me. 
 
S20 
 
 
Figure S29. 31P-NMR (121 MHz, C6D6) spectrum of 4-Me. 
 
 
Figure S30. 13C-NMR (126 MHz, C6D6) spectrum of 4-Me. 
 
 
Figure S31. 1H-NMR (500 MHz, CD3CN) spectrum of 6-Me. 
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Figure S32. 31P-NMR (121 MHz, CD3CN) spectrum of 6-Me. 
 
 
Figure S33. 13C-NMR (126 MHz, CD3CN) spectrum of 6-Me. 
 
 
Figure S34. 19F-NMR (282 MHz, CD3CN) spectrum of 6-Me. 
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Figure S35. 1H-NMR (500 MHz, d8-THF) spectrum of 8-Me. 
 
 
Figure S36. 31P-NMR (202 MHz, d8-THF) spectrum of 8-Me. 
 
 
Figure S37. 13C-NMR (126 MHz, d8-THF) spectrum of 8-Me. 
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Figure S38. 1H-NMR (300 MHz, d8-THF) spectrum of (3)H+. 
 
 
Figure S39. 31P-NMR (202 MHz, d8-THF) spectrum of (3)H+. 
 
 
Figure S40. 13C-NMR (126 MHz, d8-THF) spectrum of (3)H+. 
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Figure S41. 19F-NMR (282 MHz, CD3CN) spectrum of (3)H+. 
 
 
Figure S42. 31P-NMR (202 MHz, CD3CN). Comparison of spectrum of (3)H+. produced 
from 3 with pyridinium triflate (Top) and 6-H and dioxygen (Bottom). 
3 after pyridinium triflate addition
6-H after dioxygen addition 
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Volumetric Measurement of O2 Consumption 
Toepler Pump Experimental Details 
To determine the stoichiometry of reaction of O2 with compounds 4-H, 4-Me, and 6-H, a 
solution of the compound to be tested was degassed via three freeze-pump-thaw cycles on a 
high vacuum line. While the solution (benzene for 4-H, THF for 4-Me and 6-H) was still 
frozen, a known amount of O2 (~3-5 equiv) was measured with a volumetric Schlenk bulb 
(33.28 mL or 43.48 mL). The exact procedure then varied depending on the compound 
used. For 4-H and 6-H, the solution of compound was then warmed to room temperature 
and while stirring vigorously the O2 was then added to the reaction mixture. For 4-Me, the 
solution was warmed to -78 °C and while stirring vigorously the dioxygen was added to the 
reaction mixture while this temperature was maintained. All reactions were allowed to stir for 
1hr. During this time, the solution of 4-H and 6-H were observed to change color from 
brown/yellow and pale yellow to purple and pink respectively. No substantial color changed 
was observed following O2 addition to 4-Me at low temperature. The solution was again 
frozen, and the gas present in the headspace was measured by Toepler pump (30.23 mL 
volume). Three freeze-pump-thaw cycles were carried out on the final reaction solution to 
recover all unreacted gases. Table S1 summarizes all the separate runs of volumetric 
measurements. 
 
Table S1. Results of volumetric O2 measurements. Volumetric bulb volume = 33.28 mLa or 
43.48 mLb, Toepler pump volume = 30.25 mL. 
Run Cmpd T (K) 
mmol 
Cmpd 
O2 added 
(mmHg) 
Final O2 
(mmHg) 
mmol O2 
Consumed 
Equiv 
Consumed
1a 4-H 295 0.0902 151 197 0.0507 0.56 
2a 4-H 295 0.0928 152 197 0.0490 0.53 
3b 4-H 295 0.0850 182 234 0.0454 0.53 
4b 6-H 295 0.0808 186 224 0.0712 0.88 
5b 6-H 295 0.0800 190 227 0.0758 0.95 
6b 6-H 295 0.0750 187 226 0.0703 0.94 
7b 4-Me 295 0.0849 157 172 0.0882 1.04 
8b 4-Me 295 0.0885 157 178 0.0783 0.89 
9b 4-Me 295 0.0909 159 176 0.0863 0.95 
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ReactIR Spectra 
 
 
Figure S43. Solution ReactIR spectrum for 4-H at -78 °C before O2 addition. 
 
 
Figure S44. Solution ReactIR spectrum for 4-H at -78 °C after O2 addition. 
 
THF blank 
4-H in THF 
THF blank
4-H after O2
addition in THF
S27 
 
 
Figure S45. Solution ReactIR spectrum for 4-H after warming to -35 °C after O2 addition. 
 
 
Figure S46. Solution ReactIR spectrum for 4-H after warming to 25 °C after O2 addition. 
THF blank
4-H after O2
addition in THF 
Warming to -35 °C Intermediate
1650 cm-1 
Compound 3
1601 cm-1 
THF blank
4-H after O2
addition in THF 
Warming to 25 °C
Compound 3
1603 cm-1 
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UV/Vis Spectra 
 
 
Figure S47. Solution UV/Vis spectrum for 2. 
 
 
Figure S48. Solution UV/Vis spectrum for 3. 
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Figure S49. Solution UV/Vis spectrum for 6-H at 25 °C following O2 addition over 
multiple hours. 
 
 
Figure S50. Solution UV/Vis spectrum for the conversion of Int3 to (3)H+ after over 
multiple 12 hours. 
 
Oxidation of 4-H to 3 by Various Substrates 
Dioxygen 
4-H (10.1 mg, 0.0170 mmol, 1 equiv) was transferred to a Schlenk tube as a solution in ca. 2 
mL of THF. The solution was degassed by three freeze-pump-thaw cycles and then cooled 
to -78 °C. Excess O2 (1 atm) was then added and allowed to stir vigorously for several 
minutes. The reaction mixture was then degassed under dynamic vacuum at -78 °C while 
stirring vigorously for 8 minutes. The reaction mixture was then warmed to room 
temperature. During this time the solution immediately turned purple indicative of the 
formation of 3. Volatiles were then removed under reduced pressure and NMR of the 
residue taken in C6D6, which confirmed the quantitative formation of 3. If the reaction is run 
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in a J-Young tube in C6D6 the formation of water could be confirmed by vacuum 
transferring the volatiles of the reaction into another J-Young tube. 
 
Nitric Oxide 
4-H (10.0 mg, 0.0167 mmol, 1 equiv) was dissolved in C6D6 and transferred to a J-Young 
tube. The sample was frozen and the headspace removed. Nitric oxide (1 equiv) was 
measured in a calibrated gas bulb and then condensed into the J-Young tube. The sample 
was then warmed to room temperature. The solution turned purple as soon it thawed 
indicating the rapid formation of 3. This was confirmed by NMR which showed quantitative 
conversion to 3. The formation of water could be confirmed by vacuum transferring the 
volatiles of the reaction into another J-Young tube. 
 
Nitrous Oxide 
4-H (9.9 mg, 0.0165 mmol, 1 equiv) was dissolved in C6D6 and transferred to a J-Young 
tube. The sample was frozen and the headspace removed. Excess nitrous oxide (1 atm) was 
then added to the J-Young tube. The sample was then warmed to room temperature. The 
reaction was then monitored by NMR. The slow formation of 3 was observed by NMR over 
the course of 12 hrs, however simultaneous decomposition of 4-H typical of solution 
samples allowed to stand has also occurred. A color change from brown-yellow to a purple 
was observed over the course of the reaction. The formation of water could be confirmed by 
vacuum transferring the volatiles of the reaction into another J-Young tube. 
 
2,4,6-Tritertbutyl Phenoxyl Radical 
4-H (10.0 mg, 0.0167 mmol, 1 equiv) was dissolved in ca. 1 mL of THF and transferred to a 
20 mL scintillation vial equipped with a magnetic stirbar. 2,4,6-tritertbutyl phenoxyl radical 
(8.2 mg, 0.033 mmol, 2 equiv) as then added as a solution in ca. 1 mL THF. This resulted in 
the immediate formation of a purple solution consistent with formation of 3. The volatiles 
were then removed under reduced pressure. Successful conversion to 3 was confirmed by 
31P NMR. 
 
1-Azido Adamantane 
4-H (10.6 mg, 0.0180 mmol, 1 equiv) was dissolved in ca. 1 mL of THF and transferred to a 
20 mL scintillation vial equipped with a magnetic stirbar. 1-Azido adamantane (3.2 mg, 
0.0180 mmol, 1 equiv) was added as a solution in ca. 1 mL of THF and the reaction was 
allowed to stir for 2 hrs. During this time the solution turned from yellow-brown to purple, 
indicative of conversion to 3. The volatiles were then removed under reduced pressure. 
Successful conversion to 3 was confirmed by 31P NMR. The formation of 1-amino 
adamantine was confirmed by GC-MS comparisons to the retention time and mass data for 
an authentic sample. 
 
Trimethylamine n-oxide 
4-H (10.0 mg, 0.0166 mmol, 1 equiv) was dissolved in ca. 1 mL of MeCN and transferred to 
a 20 mL scintillation vial equipped with a magnetic stirbar. Trimethylamine n-oxide (1.3 mg, 
0.0173 mmol, 1.04 equiv) was added as a solution in ca. 1 mL of MeCN and the reaction was 
allowed to stir for 2 hrs. During this time the solution turned from yellow-brown to purple, 
indicative of conversion to 3. The volatiles were then removed under reduced pressure. 
Successful conversion to 3 was confirmed by 31P NMR. 
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1,4-Benzoquinone 
4-H (10.0 mg, 0.0166 mmol, 1 equiv) was dissolved in ca. 1 mL of THF and transferred to a 
20 mL scintillation vial equipped with a magnetic stirbar. 1,4-Benzoquinone (1.8 mg, 0.167 
mmol, 1 equiv) was then added as a solution in ca. 1 mL of THF and the reaction was 
allowed to stir for 2 hrs. During this time there was a rapid color change from brown-yellow 
to purple, indicative of conversion to 3. The volatiles were then removed under reduced 
pressure. Successful conversion to 3 was confirmed by 31P NMR. 
 
Representative Conditions for Testing Substrate Oxidation by 8-Me 
Para-trifluoromethyl benzyl alcohol 
In a Schlenk tube equipped with a magnetic stirbar, 4-Me (11.3 mg, 0.0180 mmol, 1 equiv) 
and 1,3,5-trimethoxybenzene (3.7 mg, 0.0180 mmol, 1 equiv), for an internal standard, was 
dissolved in ca. 5 mL of THF. The solution was degassed by a series of three freeze-pump-
thaw cycles, then cooled to -78 °C. Excess O2 (1 atm) was then added the solution was 
stirred vigorously to ensure complete conversion to 8-Me The solution was then degassed 
under dynamic vacuum at -78 °C while stirring vigorously for several minutes. The reaction 
was then put under a N2 atmosphere and para-trifluoromethyl benzyl alcohol (24.6 μL, 0.180 
mmol, 10 equiv) was added via syringe. The reaction mixture was allowed to stir for 4 hrs 
before a GC-MS aliquot was taken under a strong counterflow of N2. GC-MS indicated 
partial conversion to the corresponding benzaldehyde and unreacted benzyl alcohol by 
comparison to retention time and mass data for authentic samples. Addition of more 
equivalents of O2 did not lead to further conversion to product. 
 
Para-trifluoromethyl-benzaldehyde 
No oxidation of the benzaldehyde was observed by GC-MS. 
 
Cyclohexane Carboxaldehyde 
Partial conversion to cyclohexene observed by GC by comparison to retention time for an 
authentic sample. 
 
Cyclohexene 
No oxidation of cyclohexene was observed by GC. In particular, no cyclohexanone was 
observed by comparison to retention time for an authentic sample. 
 
Triphenylphosphine 
Partial conversion to triphenylphosphine oxide observed by GC-MS by comparison to 
retention time and MS data for an authentic sample. However, low temperature 31P NMR 
experiments indicate that substitution of 1-Me by 2 equivalents of PPh3 to yield 
(PPh3)2Pd(η2-O2) occurs (31P shift observed at 33.18 ppm consistent with literature data 
obtained in DMF (33.4 ppm) or CDCl3 (33.2 ppm)). By comparison to the 31P integration of 
against an internal standard of OP(OMe)3, the disappearance of 8-Me occurs at the same 
rate of 1-Me and (PPh3)2Pd(η2-O2) formation. Subsequent formation of phosphine oxide 
observed by GC-MS likely occurs from this complex rather than 8-Me. 
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Figure S51. NMR spectra taken at -78 °C in THF confirming the substitution of PPh3 for 1-
Me in solution in compound 8-Me. 
 
Methyl-para-tolyl sulfide 
No oxidation of the aryl-alkyl sulfide was observed. 
OP(OMe)3
Free PPh3
(PPh3)2Pd(η2-O2) formed by O2
addition to Pd(PPh3)4
8-Me before PPh3 addition 
Atropisomers of 1-Me 
8-Me 2 hrs after addition 
of 10 equiv of PPh3 
OP(OMe)3
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Cyclic Voltammetry Data 
Electrochemical Details 
Electrochemical measurements of complex 2 and 3 were taken on a Pine Instrument 
Company biopotentiostat model AFCBP1 as 3 millimolar solutions in tetrahydrofuran using 
0.1 molar [nBu4N][PF6] as the electrolyte with a platinum wire counter electrode, a glassy 
carbon working electrode, and a silver/silver nitrate reference electrode in 0.1 molar 
[nBu4N][PF6] as an acetonitrile solution. Electrochemical measurements of compounds were 
internally referenced to ferrocene 
 
 
Figure S52. CV data for complex 2. 
 
 
Figure S53. CV data for complex 3. 
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Crystallographic Information 
CCDC 1440560-1440565 contain the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from The Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/data_request/cif. 
Refinement details 
In each case, crystals were mounted on a glass fiber or nylon loop using Paratone oil, then 
placed on the diffractometer under a nitrogen stream. Low temperature (100 K) X-ray data 
were obtained on a Bruker APEXII CCD based diffractometer (Mo sealed X-ray tube, Kα = 
0.71073 Å). All diffractometer manipulations, including data collection, integration and 
scaling were carried out using the Bruker APEXII software.9 Absorption corrections were 
applied using SADABS.10 Space groups were determined on the basis of systematic absences 
and intensity statistics and the structures were solved by direct methods using XS 
(incorporated into SHELXTL) and refined by full-matrix least squares on F2. All non-
hydrogen atoms were refined using anisotropic displacement parameters. Hydrogen atoms 
were placed in idealized positions and refined using a riding model. The structure was 
refined (weighted least squares refinement on F2) to convergence. 
 
 
Table S2. Crystal and refinement data for reported complexes. 
Complex 2 3 4-H 5-H 6-H 7-H 
empirical 
formula 
C15H19Cl0.06Ni0.
50OP 
C32H43O2.5P2Pd C69H88O4P4Pd2
C35H48F3ClO6P2
PdS 
C31H41F3O5P2
PdS 
C32.33H43.33AgF3
O5.33P2S 
formula 
wt 277.84 636.00 1318.07 857.58 751.04 776.20 
T (K) 100 200 100 100 100 99.98 
a, Å 16.8334(5) 24.0630(6) 12.900(3) 13.040(6) 19.7535(3) 31.152(3) 
b, Å 16.8334(5) 24.0630(6) 13.564(3) 19.284(8) 19.7535(3) 31.152(3) 
c, Å 20.9194(8) 20.9789(6) 19.638(3) 15.679(6) 19.7535(3) 20.2695(18) 
α, deg 90 90 106.655(6) 90 110.8200 90 
β, deg 90 90 91.342(6) 108.373(18) 110.8200 90 
γ, deg 90 90 97.356(5) 90 110.8200 120 
V, Å3 5927.8(4) 12147.4(7) 3258.4(12) 3742(3) 5617.9(3) 17035 
Z 16 16 4 4 6 18 
cryst syst Tetragonal Tetragonal Triclinic Monoclinic Rhombohedral Trigonal 
space 
group P2/ncc P-421c P-1 P121/n1 R3cR R3c 
dcalcd, 
g/cm3 1.245 1.391 1.344 1.515 1.332 1.362 
θ range, 
deg 1.711 to 36.343 1.197 to 37.310 1.583 to 37.026 1.729 to 36.211 2.17 to 29.22 2.147 to 30.664 
μ, mm-1 0.797 0.745 0.696 0.767 0.685 0.723 
abs cor 
Semi-empirical 
from 
equivalents 
Semi-empirical 
from 
equivalents 
Semi-empirical 
from 
equivalents 
Semi-empirical 
from 
equivalents 
Semi-empirical 
from 
equivalents 
Semi-empirical 
from 
equivalents 
GOFc 0.952 1.167 0.874 1.022 0.972 0.904 
R1,a 
wR2b (I 
> 2σ(I)) 
0.0406, 0.1039 0.0527, 0.0995 0.0521, 0.0944 0.0529, 0.1286 0.0318, 0.0720 0.0475, 0.1239 
a R1 = ||Fo|-|Fc|| / |Fo|     b wR2 = {  [w(Fo2-Fc2)2] /  [w(Fo2)2] }1/2     c GOF = S = 
{  [w(Fo2-Fc2)2] / (n-p) }1/2 
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